...
首页> 外文期刊>Breast care >A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer
【24h】

A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer

机译:回顾性分析2种低分次放疗方案与传统的乳腺癌乳房切除术后辅助放疗方案的毒性和功效

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: The aim of this analysis was a retrospective evaluation of the efficacy and toxicity of 2 hypofractionated irradiation schedules compared to conventional therapy in post-mastectomy patients. Methods: 3 irradiation schedules were analyzed: 48.30 Gy in 21 fractions (group A, n = 60), 42.56 Gy in 16 fractions (group B, n = 27) and 50 Gy in 25 fractions (group C, n = 30) of the front chest wall. All groups were also treated with a supraclavicular field, with 39.10 Gy in 17 fractions (group A), 37.24 Gy in 14 fractions (group B) or 45 Gy in 25 fractions (group C). Results: No local recurrences were noted in any group during 36 months of follow-up. Acute skin toxicity presented in all groups, with 58.3%, 70.4% and 60% of grade I; 35%, 25.9% and 40% of grade II; 6.7%, 3.7% and 0% of grade III being seen in groups A, B and C, respectively. Late skin toxicity was noted only as grade I in 16.7%, 25.9% and 26.7% of groups A, B and C, respectively. No significant difference was noted among all groups for either acute or late skin toxicity, or for radio-pneumonitis (chi(2) test, p > 0.05). Conclusion: All schedules were equally effective with equivalent toxicity. A prospective randomized study is needed to confirm our results. (C) 2016 S. Karger GmbH, Freiburg
机译:简介:这项分析的目的是回顾性评估乳房切除术后患者与常规治疗相比的两种次分割照射方案的疗效和毒性。方法:分析了3个照射时间表:21个组分中的48.30 Gy(A组,n = 60),16个组分中的42.56 Gy(B组,n = 27)和25个组分(C组,n = 30)中的50 Gy。前胸壁。所有组还用锁骨上区域进行治疗,分别以17份39.10 Gy(A组),14份37.24 Gy(B组)或25份45 Gy(C组)。结果:在随访的36个月中,任何组均未发现局部复发。所有组均出现急性皮肤毒性反应,分别占I级的58.3%,70.4%和60%; II级的35%,25.9%和40%;在A,B和C组中分别发现了III级的6.7%,3.7%和0%。晚期皮肤毒性仅在A,B和C组分别为16.7%,25.9%和26.7%达到I级。在所有组中,急性或晚期皮肤毒性或放射性肺炎均无显着差异(chi(2)测试,p> 0.05)。结论:所有方案在等效毒性下均有效。需要进行前瞻性随机研究以证实我们的结果。 (C)2016 S.Karger GmbH,弗赖堡

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号